Biopharming is the process of producing (or 'farming') medicinal compounds for therapeutic use using transgenic plants or animals. This entails putting target genes into hosts (crops or animals) that would not usually express them. The desired component may be expressed in a form that may be harvested on a regular basis (e.g., milk, eggs, fruits, etc.). The use of crops for bio-production of a recombinant protein (i.e., enzyme or antibody) or a system that includes bioreactors in vitro is referred to as biopharming. In comparison to industrial expenses, this approach provides great economic and health benefits, aided by new biotechnology methods that are improving. Plant biopharming is described as the cultivation of transgenic plants that have been genetically modified to produce "humanised" medicinal compounds for human use. "Molecular farming" is another term for biopharming. Corn, soybeans, rice, tobacco, and potatoes engineered to generate a material, usually a protein, vaccines, in their fruit, leaves, seeds, or tubers, are the most popular plants now being investigated for biopharming.
Title : A review of nanomaterials in humans
Thomas J Webster, Hebei University of Technology, United States
Title : Biosurfactants: Production and novel applications
Cristiano Jose de Andrade, Federal University of Santa Catarian (UFSC), Brazil
Title : Tailoring composition, bioactivity, and porous structure of 3D-printed scaffolds for tissue engineering
Dario Puppi, University of Pisa, Italy
Title : From mesenchymal stromal/Stem cells to insulin-producing cells: Progress and challenges
Mohamed A Ghoneim, Urology and Nephrology Center, Egypt
Title : ChAgG-PCL/PVP electrospun fibers as wound dressings
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico
Title : Engineering of extracellular vesicles for nanomedicine applications
Tania Limongi, Politecnico di Torino, Italy